These approaches have identified six major molecular subtypes of breast cancer (luminal A, luminal B, HER2-enriched, triple-negative/basal-like, normal breast-like, and claudin-low)7, each displaying different phenotypic and molecular features and which have distinct clinical outcomes. The gene discussed is ERBB2; the disease is breast carcinoma.